▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

AngioDynamics (NASDAQ: ANGO)

$9.46

(0.5%)

$0.04

Price as of May 23, 2025, 3:58 p.m. ET

AngioDynamics Return vs. S&P

	1 Year	5 Year	5 Year Annualized	Since IPO
ANGO	+54.41%	-14.79%	-3.15%	-24%
S&P	+10.16%	+96.34%	+14.43%	+418%

AngioDynamics Company Info

AngioDynamics, Inc. is a medical device company, which engages in the development, manufacture, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. It offers ablation systems, fluid management systems, vascular access, angiographic, drainage. thrombolytic, and venous products. The company was founded by Eamonn P. Hobbs on February 9, 1988 and is headquartered in Latham, NY.

News & Analysis

The Fool has written over 100 articles on AngioDynamics.

Featured Article

Why AngioDynamics Stock Is Crashing Today

Investors didn't like the medical technology company's fiscal 2025 Q1 update.

Keith Speights | Oct 3, 2024

Featured Article

Why AngioDynamics Stock Got Destroyed Today

The medical technology company is a perennial underperformer, but its latest quarterly report was worse than expected.

Rich Smith | Jan 5, 2024

Why Angiodynamics Stock Sank Today

Eric Volkman | Oct 4, 2023

The company didn't get investors excited about its latest set of quarterly figures.

Why AngioDynamics Stock Popped on Monday

Rich Smith | Sep 25, 2023

AngioDynamics has fascinating technology, but few prospects for profits.

Should Growth Investors Buy This Revolutionary Small-Cap Stock?

Kody Kester | Jul 25, 2023

The medical devices company is taking an exciting approach to treating some of the most complex diseases.

Why Shares of AngioDynamics Rose Friday

Jim Halley | Jun 9, 2023

The medical technology company sold some of its assets to pay down its debt.

Wall Street Thinks This Small-Cap Stock Can Double in Value

Kody Kester | Apr 4, 2023

Analysts are projecting a huge rebound from this beaten-down stock in the next 12 months.

Is This Under-the-Radar Growth Stock a Buy?

Kody Kester | Jan 19, 2023

This company is a small player in the steadily growing medtech industry.

Valuation

Earnings Transcripts

Angiodynamics Inc (ANGO) Q1 2022 Earnings Call Transcript

ANGO earnings call for the period ending August 31, 2021.

Motley Fool Transcribers | Sep 30, 2021

Angiodynamics Inc (ANGO) Q4 2021 Earnings Call Transcript

ANGO earnings call for the period ending May 31, 2021.

Motley Fool Transcribers | Jul 13, 2021

AngioDynamics Inc (ANGO) Q3 2021 Earnings Call Transcript

ANGO earnings call for the period ending February 28, 2021.

Motley Fool Transcribers | Mar 30, 2021

AngioDynamics Inc (ANGO) Q2 2021 Earnings Call Transcript

ANGO earnings call for the period ending November 30, 2020.

Motley Fool Transcribers | Jan 7, 2021

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services